Cardinal Health Management
Management criteria checks 3/4
Cardinal Health's CEO is Jason Hollar, appointed in Sep 2022, has a tenure of 3.25 years. total yearly compensation is $18.98M, comprised of 7.9% salary and 92.1% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth $10.73M. The average tenure of the management team and the board of directors is 3.5 years and 4.3 years respectively.
Key information
Jason Hollar
Chief executive officer
US$19.0m
Total compensation
| CEO salary percentage | 7.86% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3.5yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.5107
Nov 08
Cardinal Health: Quiet Transformation, Clear Buy
Nov 05Why Investors Shouldn't Be Surprised By Cardinal Health, Inc.'s (NYSE:CAH) 26% Share Price Surge
Nov 05Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5107
Sep 23Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today
Jul 28Investors Still Waiting For A Pull Back In Cardinal Health, Inc. (NYSE:CAH)
Jun 20Cardinal Health's (NYSE:CAH) Shareholders Will Receive A Bigger Dividend Than Last Year
May 09Cardinal Health (NYSE:CAH) Is Looking To Continue Growing Its Returns On Capital
Apr 27Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5056
Mar 25Cardinal Health, Inc. (NYSE:CAH) Not Flying Under The Radar
Feb 25Cardinal Health's (NYSE:CAH) Dividend Will Be $0.5056
Feb 07Cardinal Health: Demand For Medical Supplies To Grow, But Negative Equity Persists
Jan 09Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today
Jan 03Cardinal Health Q1 Earnings: Margins Signal More Upside
Nov 04
Expanding Oncology And Specialty Solutions To Drive Revenue And Profitability Amidst Evolving Challenges
Cardinal Health's emphasis on enhancing its Specialty Solutions in oncology and strategic partnerships aims to boost revenue growth.Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health Is Setting Up For A Great 2024
Dec 21CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$2b |
| Jun 30 2025 | US$19m | US$1m | US$2b |
| Mar 31 2025 | n/a | n/a | US$2b |
| Dec 31 2024 | n/a | n/a | US$1b |
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | US$26m | US$1m | US$852m |
| Mar 31 2024 | n/a | n/a | US$622m |
| Dec 31 2023 | n/a | n/a | US$706m |
| Sep 30 2023 | n/a | n/a | US$208m |
| Jun 30 2023 | US$19m | US$1m | US$330m |
| Mar 31 2023 | n/a | n/a | US$463m |
| Dec 31 2022 | n/a | n/a | -US$1b |
| Sep 30 2022 | n/a | n/a | -US$1b |
| Jun 30 2022 | US$4m | US$729k | -US$938m |
| Mar 31 2022 | n/a | n/a | -US$955m |
| Dec 31 2021 | n/a | n/a | US$555m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | US$4m | US$700k | US$611m |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | n/a | n/a | US$1b |
| Sep 30 2020 | n/a | n/a | US$973m |
| Jun 30 2020 | US$4m | US$124k | -US$4b |
Compensation vs Market: Jason's total compensation ($USD18.98M) is above average for companies of similar size in the US market ($USD13.44M).
Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.
CEO
Jason Hollar (52 yo)
Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.3yrs | US$18.98m | 0.023% $ 10.7m | |
| Chief Financial Officer | 2.8yrs | US$6.21m | 0% $ 0 | |
| Chief Legal & Compliance Officer | 6.8yrs | US$4.93m | 0.0055% $ 2.6m | |
| Chief Executive Officer of GMPD segment | 6.3yrs | US$4.75m | 0.011% $ 5.1m | |
| Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 3.3yrs | US$5.51m | 0.022% $ 10.5m | |
| Senior VP & Chief Accounting Officer | 3.3yrs | no data | 0.0015% $ 694.6k | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Human Resources Officer | 7.2yrs | no data | 0.0064% $ 3.0m | |
| President of Biopharma Solutions & Strategic Sourcing | no data | no data | no data | |
| Senior Vice President | 2.8yrs | US$1.26m | no data | |
| President of Global Operations & Supply Chain | 4.8yrs | no data | no data | |
| President of Cardinal Health at-Home Solutions | 3.8yrs | no data | no data |
Experienced Management: CAH's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.3yrs | US$18.98m | 0.023% $ 10.7m | |
| Independent Non-Executive Chairman | 18.3yrs | US$570.01k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$319.95k | 0% $ 0 | |
| Independent Director | 12.3yrs | US$341.95k | 0.0061% $ 2.9m | |
| Independent Director | 5.4yrs | US$321.95k | 0% $ 0 | |
| Independent Director | less than a year | US$172.49k | no data | |
| Independent Director | less than a year | US$172.49k | no data | |
| Independent Director | 5.3yrs | US$339.95k | 0.0017% $ 808.0k | |
| Independent Director | 10.3yrs | US$339.95k | 0% $ 0 | |
| Independent Director | 7.8yrs | US$346.95k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$321.95k | 0.0013% $ 600.1k | |
| Independent Director | 3.3yrs | US$319.95k | 0.0029% $ 1.4m |
Experienced Board: CAH's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/09 05:40 |
| End of Day Share Price | 2025/12/09 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cardinal Health, Inc. is covered by 32 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Eric Coldwell | Baird |
| Lawrence Marsh | Barclays |